PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Disease, University of Utah School of Medicine, Salt Lake City, UT, USA.\', \'Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA.\', \'Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.\', \'Maurice Wilkins Center, University of Auckland, Auckland, New Zealand.\', \'Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC27599, USA.\', \'Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.\', \'Faculty of Medicine, Institute of Global Health, University of Geneva, Geneva, Switzerland.\', \'Division of Microbiology & Immunology, University of Utah School of Medicine, Salt Lake City, UT, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1017/S0950268821002764
?:hasPublicationType
?:journal
  • Epidemiology and infection
is ?:pmid of
?:pmid
?:pmid
  • 35068405
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.128
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35068405>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35068405>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all